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Background: Our aim in the present study was to compare patients presenting with gastroesophageal reflux
disease in the presence or absence of mild-grade esophagitis (grade I or II according to the Savary-Miller
classification).
Methods: Between 2005 and 2007, 215 patients with gastroesophageal reflux disease (67 with reflux associated
with grade I or II esophagitis and 148 without esophagitis) were evaluated at the Department of Surgery, University
Hospital Tor Vergata, Rome, and were included in the present study. The evaluations consisted of clinical interviews,
endoscopy of the high digestive tract, esophageal manometry and pH monitoring.
Results: There was no significant difference between the two groups with regard to age, sex or symptoms. The
incidence of heartburn associated with noncardiac chest pain was greater in the esophagitis group than in the
dysphagia group. The incidence of hiatal hernia was similar in both groups. Although the motor pattern was similar
in both groups, the length of the abdominal esophagus was greater in patients without esophagitis (1.6 cm vs
1.1 cm; P< 0.05). The reflux pattern was nearly identical in both groups.
Conclusions: Gastroesophageal reflux without esophagitis must be regarded not as a milder form of the disease
but as part of a single disease. Furthermore, these patients often demonstrate lower rates of symptom
improvement after antireflux treatment in comparison with patients with erosive esophagitis. Therefore, further trials
to assess the treatment algorithm for these patients are warranted.
Keywords: Antireflux surgery, Gastroesophageal reflux disease, Nonerosive reflux disease, Erosive esophagitis,
24-hour pH-metryBackground
Gastroesophageal reflux disease (GERD) represents an
important medical problem in Western countries: about
20% of the population in Western countries complain of
experiencing typical symptoms of this disease (heartburn
and acid regurgitation). Furthermore, the incidence is
probably underestimated, because many patients have
extraesophageal symptoms such as asthma, cough,
hoarseness and chest pain [1,2].* Correspondence: fede.cadeddu@libero.it
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reproduction in any medium, provided the orGERD is associated with a variety of lesions, including
esophageal erosion, ulceration, stricture and Barrett’s
esophagus. Reflux-related symptoms and lesions do not
necessarily coexist, however, given that about 30% to
70% of patients who complain of typical symptoms have
no signs of esophagitis based on endoscopy [1]. There-
fore, nonerosive reflux disease (NERD) and erosive
esophagitis (EE) represent the most common clinical
features of GERD. The increasing use of 24-hour pH-
metry allowed us to select patients with or without an
increase in the acidification time of the esophagus.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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NERD and EE patients have found that patients with
NERD have the following morphologic and functional
patterns: lower esophageal sphincter (LES) pressure,
minimal esophageal body motility abnormalities, lower
esophageal acid exposure profile, low prevalence of hia-
tal hernia (HH) and minimal nighttime esophageal ex-
posure. Moreover, NERD patients present with a lower
incidence of acid reflux events than do patients with re-
flux esophagitis and Barrett’s esophagus.
It has been suggested that NERD is a disease in itself,
different from EE and Barrett’s esophagus. Actually, it
can be hard to diagnose NERD patients, either in either
clinical practice or clinical research. NERD patients may
present with symptoms as severe as those with EE, and
the impairment in quality of life may be similar to that
of GERD patients with or without endoscopically diag-
nosed esophagitis.
In the literature, investigators in different trials have
compared patients with NERD with those with GERD, but
without taking into account the degree of esophagitis. We
that this represents a significant bias and could affect the
data obtained from pH-metric and manometric tests.
Our aim in the present study was to compare the
characteristics of reflux episodes in patients with NERD
and EE, considering only those with hyperemia, edema,
friability, pallor or erosions of the esophageal mucosa
(grade I or II esophagitis according to the Savary-Miller
classification).
Methods
Between 2005 and January 2007, 215 patients with
GERD symptoms were evaluated at the Department of
Surgery, Tor Vergata University Hospital, Rome, and
were included in this prospective, nonrandomized study.
The study was approved by the Institutional Committee
of the Tor Vergata University of Rome.
All patients underwent a complete evaluation, including
esophagogastroduodenoscopy (EGDS), esophageal manom-
etry with a six-channel computerized perfusion tube, and
24-hour esophageal pH monitoring using antimony mono-
crystalline electrodes with or without a separate skin refer-
ence electrode. In the presence of respiratory symptoms,
antimony with two electrodes at 10 cm was adopted.
The 215 patients had neither undergone previous ab-
dominal surgery nor used any kind of drugs influencing
esophageal motility at the time of the clinical evaluation.
Proton pump inhibitor (PPI) or H2 inhibitor therapy
was interrupted at least 1 week before pH monitoring
and esophageal manometry.
All patients with endoscopic findings of GERD were
analyzed, but only patients with Savary-Miller grade I or
II esophagitis were included. The following were the cri-
teria for inclusion in the study:1. Patients with nonerosive esophagitis symptoms:
mucosal changes such as erythema, edema, friability
or pallor
2. Patients with EE: erosions in the esophageal mucosa
in addition to the changes mentioned in item 1
3. Absence of endoscopic evidence of GERD, but with
positive pH-metry
Pathologic reflux was assessed on the basis of the pH-
monitoring pattern, even in the absence of features of
esophagitis upon EGDS.
In addition to demographics, the presence of heartburn,
dysphagia, noncardiac chest pain (NCCP) and respiratory
symptoms possibly linked to reflux were recorded. In every
patient who complained of asthmalike symptoms, retro-
sternal chest pain and pharyngeal constriction, pneumato-
logical or otolaryngological evaluations were performed.
HH was assumed to be present if the stomach protruded
more than 2 cm through the esophageal hiatus.
Manometric studies were performed to evaluate the LES
for amplitude, length and capacity of relaxation upon
swallowing. The features and morphology of the swallow-
ing complexes were analyzed together with the propaga-
tion of peristaltic waves in the body of the esophagus.
Intraesophageal pH readings were recorded using a
Digitrapper pH 400 (Medtronic Functional Diagnostic
A/S, Skovlunde, Denmark). An antimony pH catheter
(Medtronic Inc, Minneapolis, MN, USA) was inserted
transnasally with the patient under local anesthesia and
placed 5 cm distal to the gastric cardia, and pH readings
were recorded for 24 hours.
The analysis of the pH monitoring included the fol-
lowing parameters:
1. Total number of reflux episodes
2. Total number of pathological episodes of reflux
(pH< 4 for more than 5 minutes)
3. Percentage of reflux time compared with total
monitoring time (total reflux time)
4. Percentage of reflux time compared with the time
while the patient was in the upright position (reflux
time in erect position)5. Percentage of reflux time
compared with the time while the patient was lying
down (reflux time in supine position)
5. Johnson and DeMeester composite scoring system
score (based on the above-mentioned parameters) [2]
The following are the normal values of the above-men-
tioned parameters:
1. Total reflux time up to 3.2%
2. Reflux time in erect position up to 8.2%
3. Reflux time in supine position up to 3%
4. Johnson and DeMeester score up to 14.7 (>6 or 7 up
to 10) [2]
Table 1 Demographic characteristics of the 215 patients according to the presence or absence of reflux esophagitisa
Demographic variables RE patients, n (%) RE-free patients, n (%) Total patients, n (%)
Number of patients 67 (31.2) 148 (68.8) 215 (100)
Men 23 (34.3) 60 (40.5) 83 (38.6)
Women 44 (65.7) 88 (59.5) 132 (61.4)
Age range, years (median) 24 to 74 (48.87) 17 to 73 (50.10) 17 to 74 (49.72)
Total 67 (100.0) 148 (100.0) 215 (100.0)
aRE, reflux esophagitis.
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vey questionnaire for all patients.Statistical analysis
All statistical elaborations were obtained by using statis-
tical software for Windows XP (Statgraphics, version 6).
Results are expressed as values and standard deviation
(means ± SD).
Nonparametric tests were used to analyze the results,
taking into account the nature of the variables. The fol-
lowing tests were applied: Student’s t-test for numerical
data and a χ2 test with Yates’s correction for qualitative
data. In all tests, 0.05 or 5% was established as the level
for rejecting the hypothesis.Results
Between 2005 and January 2007, 258 consecutive
patients with GERD symptoms were evaluated at the
Department of Surgery, Tor Vergata University Hospital,
Rome. Of the 258 patients, 43 (16.7%) with Savary-Miller
grade III or IV esophagitis were excluded from our
study. Therefore, 215 patients were evaluated and
included in this prospective, nonrandomized trial.
The baseline characteristics of the two groups are
shown in Table 1. Sixty-seven patients (31.2%) reported
reflux associated with Savary-Miller grade I or II esopha-
gitis (RE patients), and 148 patients (68.8%) showed no
evidence of esophagitis (RE-free patients).
There were no statistically significant differences be-
tween the two groups regarding presence of HH (χ2 =
0.259; P> 0.05), LES pressure values (χ2 = 67.50; P>
0.05) or total reflux time (χ2 = 55.50; P> 0.05). Heart-
burn occurred in 38.8% of RE patients and 61.5% of theTable 2 Clinical characteristics of the 215 patients according
Symptoms RE patients, n (%) RE-fre
Heartburn 26 (38.8) 91 (61
Chest pain 12 (17.9) 34 (23
NCCP heartburn 26 (38.8) 14 (9.4
Dysphagia 3 (4.5) 0 (0)
Extraesophageal symptoms 0 (0) 9 (6.1)
Total 67 148
aNCCP, noncardiac chest pain; NS, not statistically significant.RE-free group, and the difference was statistically signifi-
cant (Fisher’s exact test; P< 0.001). A significant associ-
ation between heartburn and NCCP was recorded in
38.8% of RE patients and 9.4% of the RE-free group
(χ2 = 24.811; P = 0.0001).
Retrosternal pain was more evident in RE-free than in
RE patients (23.0% vs 17.9%, χ2 = 0.260; P> 0.05), but the
difference was not significant. Dysphagia was detected
only in the RE group (4.5%, χ2 = 3.860; P = 0.049), and
extraesophageal symptoms were noted only in the RE-free
group (6.1%, χ2 = 2.871; P> 0.05) (Table 2).
The results of manometric studies of the esophagus
were substantially similar in the two groups of patients.
The only statistically relevant difference was the length of
the abdominal esophagus (χ2 = 14.24; P = 0.05) (Table 3).
Prolonged esophageal pH monitoring, carried out in
all patients, showed no significant differences between
the two groups regarding total reflux time or reflux time
in either the erect or supine position (χ2 = 65.59; P>
0.05). There was no significant difference in Johnson
and DeMeester scores between RE patients and RE-free
patients (F-ratio = 0.86; P> 0.05) (Table 4).Discussion
A significant number of patients with classical esopha-
geal reflux symptoms do not show endoscopic evidence
of esophagitis. This group was regarded as having an
attenuated form of gastroesophageal reflux (GER).
Kasapidis et al. [3] defined pathologic GER patients as
only those with suggestive symptoms confirmed by pH
monitoring. In accord with Nasi et al. [4], we do not agree
with that definition, which does not take into account the
significant group of symptomatic patients with esophagitisto the presence or absence of reflux esophagitisa
e patients, n (%) Total patients, n (%) P values
.5) 117 (51.6) 0.001
) 46 (21.4) NS




Table 3 Manometric pattern of the 215 patients according to the presence or absence of reflux esophagitisa
Measured parameters RE patients (mean values) RE-free patients (mean values) P values
LES pressure (normal value = 14.3 to 34.5 mmHg) 15.3 mmHg 16.8 mmHg NS
Length of abdominal LES 1.1 cm 1.6 cm 0.05
Amplitude pressure waves (normal value = 64 to 154) 74.7 mmHg 73.8 mmHg NS
Duration pressure waves (normal value = 2.9 to 5.1 seconds) 3.2 seconds 3.1 seconds NS
Motor alteration of esophageal body 71.9% 67.9% NS
aRE, reflux esophagitis; LES, lower esophageal sphincter; NS, not statistically significant.
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to identify pathologic reflux in patients with esophagitis
suggests that factors other than acidity, such as pepsin
and bile salts, are involved in the pathogenesis of GERD.
Patients without endoscopic or pH-metric evidence of
GER have been defined as having functional heartburn
[3]. This may be due to hypersensitivity to acidic or
other nonacidic factors, which could fire up their heart-
burn. On the other hand, increased sensibility to acid of
esophageal chemoreceptors was found in patients with-
out RE, even if they had a sensitivity to these factors
lower than that of patients with EE [4].
On the basis of symptoms, the differential diagnosis
between GERD with RE and NERD is really challenging.
In our experience, patients with NERD complained of
extraesophageal symptoms and retrosternal pain more
often than RE patients and had a lower incidence of dys-
phagia. Nonetheless, these differences were not statisti-
cally significant.
In our series, in contrast to results reported by other
authors, the impact of heartburn was significantly higher
in patients without esophagitis than in those with it (P
< 0.001). Moreover, the presence of heartburn with pain
was more frequent in patients with esophagitis than in
those without it (P< 0.0001).
In agreement with several other researchers, we found
that the incidence of symptoms in GERD patients with
versus without esophagitis is similar [5,6]. Therefore, we
cannot assume the presence of reflux disease with or
without esophagitis based solely on symptoms.
EGDS in the present study detected HH in 144
patients overall (67%), comprising 47 patients (70%) in
the esophagitis group and 97 patients (65.5%) in the
nonesophagitis arm, without significant differences be-
tween the two groups. On the contrary, other authorsTable 4 pH-metric pattern of the 215 patients according to th
Measured parameters RE patients (mean values)
Total reflux number 140.6
Reflux number >5 minutes 3.8
pH time <4 minutes 166.4
Reflux in supine and erect 69.6%
Johnson and DeMeester score 32.8
aRE, reflux esophagitis; NS, not statistically significant.have found a higher incidence of HH in patients with
esophagitis [4,7]. Actually, HH is considered a risk factor
because it reduces esophageal clearance [4,8-10]. Mittal
et al., who based their findings on esophageal scintig-
raphy to assess esophageal clearing time, observed that
clearing time was shorter in patients with HH [9].
DeMeester et al. found an association between the pres-
ence of HH and severe acidic exposure of the esophageal
mucosa detected by pH-metry [11].
Although total reflux time is considered the key factor
in diagnosing GERD patients, in agreement with other
authors, we found no difference among patients with
versus those without esophagitis regarding total reflux
time and Johnson and DeMeester score.
Likewise, Nasi et al. [4] believed that decreased resist-
ance of the esophageal mucosa and the presence of
harmful agents in the reflux (pepsin and/or bile salts),
which are poorly assessed by esophageal pH monitoring,
may contribute to GERD. Similarly, Pujol et al. found
that there was no statistically significant difference in
the number of episodes of reflux, time of reflux and
Johnson and DeMeester score in patients with versus
those without esophagitis [12].
In a pH-metric data analysis, Quigley et al. reported
more than 75% of RE patients and about 50% to 65% of
non-RE patients presented with alterations of esophageal
acidification time [13]. In our experience, the presence
of multiple episodes of pathological GER was found in
53.9% of patients with RE and in 52.2% of patients with-
out RE (P> 0.05).
Clinically high-grade esophagitis is often encountered
in association with motility dysfunction of the lower
esophagus and normal LES pressure values. In our ex-
perience, similar to that described by Almeida et al. [14],
statistical analysis of esophageal motility parameterse presence or absence of reflux esophagitisa
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groups, with the exception of the length of the intraab-
dominal esophagus, which was longer in the group with-
out RE (1.6 cm vs 1.1 cm; P< 0.05).
Regarding the manometric pattern, in contrast to other
authors who found motor impairments of the esophageal
body in RE patients [4,15], we found no difference be-
tween the two groups in terms of LES pressure and ab-
dominal and total extension of the sphincter. On the
contrary, Wu et al. found a higher prevalence of esopha-
geal dysmotility in non-RE patient [4,16]. Actually, patient
selection is a key factor. In our study, patients with
Savary-Miller grade III or IV esophagitis were not consid-
ered, in contrast to studies by other investigators who did
not differentiate patients according to esophagitis grade.
Fass et al. [17] and Schindlbeck [18] found that in the
emergency room, patient biopsies of the esophageal mu-
cosa during EGDS could be another useful diagnostic
tool. These authors reported a higher rate of inflamma-
tory cells (for example, neutrophilic and eosinophilic
granulocytes) as well as greater epithelial hyperplasia or
mucosal vessel dilatation in histological specimens of
both RE patients without esophagitis and non-RE
patients with altered pH tests than in controls or non-
RE patients with normal pH-metry [17,18].
We found no difference in quality of life between the
two groups, although we did not use specific question-
naires to evaluate the quality of life in the first part of
our clinical experience. Previously, patients with endos-
copy-negative reflux disease were considered to have
milder disease. This concept is incorrect, given that the
impact on quality of life is similar in GERD patients with
or without esophagitis and is related to symptoms in
both cases [17-20].
In patients who present with alarm symptoms, such as
dysphagia, weight loss, anorexia and anemia, EGDS
should be regarded as the first-line diagnostic approach.
In contrast, patients who present with typical symptoms
of GERD but without alarm symptoms will most likely
be treated empirically, without the patient’s or the physi-
cian’s knowing whether there is an esophageal mucosal
injury [21]. Only 25% of the patients without esophagitis
who initially achieved complete symptom resolution
while taking PPIs will remain symptom-free after
6 months without any antireflux therapy [22]. These
findings suggest that most patients without esophagitis
will require long-term therapy, regardless of the treat-
ment that initially induces symptom remission.
Therefore, we do not agree with empirical PPI therapy,
especially in young patients. We suggest performing con-
tinuous 24-hour pH monitoring in all patients to exclude
or confirm the presence of duodenogastroesophageal re-
flux. Actually, the absence of pathological reflux during
pH-metric monitoring could be useful by excluding thepresence of acid reflux but cannot be used to detect epi-
sodes of alkaline refluxes, which can be investigated only
with spectrophotometry of biliar pigments.
Conclusions
In conclusion, we believe that NERD does not represent
a different form of GERD, but that it should be consid-
ered an aspect of this condition with unique diagnostic
and therapeutic features. Therapy must be tailored to
each patient according to clinical and instrumental find-
ings, especially in those patients who show good compli-
ance and acceptable improvement in symptoms with
“on-demand” or intermittent drug administration. Fi-
nally, surgery should be considered among the thera-
peutic options for well-selected patients with persistent
reflux-associated symptoms and no endoscopic evidence
of esophagitis, but with pathological pH values.
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